PTEN and colorectal carcinoma: Another study investigating the prognostic role of KRAS, BRAF, PIK3CA mutations, and PTEN expression in two separate CRC cohorts of 197 and 414 patients respectively, observed absence of correlation between PTEN status and prognosis by analyzing each molecular marker separately (41).